Pulmonary A2 strain respiratory syncytial virus infection of BALB/c laboratory mice persisted for up to 7 days after initial infection with peak virus titres being recovered on day 4. Virus antigen within the lungs was found to be restricted essentially to the alveolar regions. Similarly, pulmonary histopathological changes remained confined to the peri-alveolar regions being consistent with mild pneumonia. Infection was found to elicit a pulmonary major histocompatibility complex-restricted cytotoxic T lymphocyte (CTL) response which was first detectable 6 days after infection and optimal 7 to 9 days after infection. This local CTL response was preceded by a rapid transient virus-specific lymphocyte transformation response which was detectable only 3 days after intranasal infection. In addition, infection induced rapid interferon production within the lungs which was accompanied by an equally rapid rise in pulmonary natural killer (NK) cell cytotoxic activity. Enhanced NK cell cytotoxicity could be detected after only 1 day post-infection and continued to rise to maximum levels on day 3. This response like the acute CTL response was found to be restricted to the lower respiratory tract. IgG was the first class of virus-specific immunoglobulin to be detected in the lungs of infected animals after experimental infection. However, IgG was not detected until day 10 post-infection, 5 days after the initial decline of virus shedding. Virus-specific IgA although detectable did not appear in the lung until day 24.
AlsheikhlyA. R.,
ÖrvellC.,
HarfastB.,
AndersonT.,
NorrbyE.1983; Sendai virus-induced cell mediated cytotoxicity in vitro: the role of viral glycoproteins in cell mediated cytotoxicity. Scandinavian Journal of Immunology 111:129–138
BanghamC.R.M.,
AskonasB. A.1986; Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus. Journal of General Virology 67:623–629
CannonM. J.,
StottE. J.,
TaylorG.,
AskonasB. A.1987; Clearance of persistent RSV infections in immunodeficient mice following transfer of primed T cells. Immunology 62:133–138
CharltonD.,
BlandfordG.1977; Immunoglobulin class specific antibody response in serum, spleen, lungs and bronchioal- veolar washings after primary and secondary Sendai virus infection of germ free mice. Infection and Immunity 17:521–527
ChinJ.,
MagoffinR. L.,
SheaperL. A.,
SchiebleJ. H.,
LennetteE. H.1969; Field evaluation of a respiratory syncytial virus vaccine and a trivalent influenza virus vaccine in a pediatric population. American Journal of Epidemiology 89:449–463
CranageM. P.,
GardnerP. S.1980; Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections. Journal of Medical Virology 5:161–170
DreizenR. S.,
VyshnevetskayaL. O.,
BagdamyanE. E.,
YankevichO. D.,
TarasovaL. B.,
KlenovaA. V.1971; Study of experimental RS virus infection in cotton rats. Virologic and immunofluorescent studies. Voprosy virusologii 16:670–676
FinterN. B.1969; Dye uptake methods for assessing viral cytopathbgenicity and their application to interferon assays. Journal of General Virology 5:419–427
HorfastB.,
ÖrvellC.,
AlsheikhlyA.R,
PerlmanP.,
NorrbyE.1980; The role of viral glycoproteins in mumps virus dependent lymphocyte mediated cytotoxicity in vitro. Scandinavian Journal of Immunology 11:391–400
KapikianA. Z.,
MitchellR. H.,
ChanockR. M.,
SchevedoffR,
StewartC. E.1969; An epidemiological study of altered clinical reactivity to respiratory syncytial virus infection in children previously vaccinated with an inactivated RS virus vaccine. American Journal of Epidemiology 89:401–421
KimH. W.,
BellantiJ. A.,
ArrobioJ. O.,
MillsJ.,
BrandtC. D.,
ChanockR. M.,
ParrottR. H.1969; Respiratory syncytial virus neutralising activity in nasal secretions following natural infection. Proceedings of the Society for Experimental Biology and Medicine 131:658–661
KumagiT.,
WongD. T.,
OgraP. L.1985; Development of cell- mediated cytotoxicity activity in the respiratory tract after experimental infection with respiratory syncytial virus. Clinical and Experimental Immunology 61:351–359
McintoshK.,
McquillinJ.,
GardnerP. S.1979; Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial infection. Infection and Immunity 23:276–281
MitoK.,
ChibaY.,
SugaK.,
NakaoT.1984; Cellular immune response to infection with respiratory syncytial virus and influence of breast feeding on the response. Journal of Medical Virology 14:323–332
MurphyB. R.,
PrinceG. A.,
WalshE. E.,
KimH. W.,
ParrottR. H.,
HemmingV. G.,
RodriguezW. J.,
ChanockR. M.1986; Disassociation between serum neutralising and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. Journal of Clinical Microbiology 24:197–202
OpenshawP.J.M.1989; Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial virus. Clinical and Experimental Immunology 75:324–328
OwensS. L.,
OseboldJ. W.,
ZeeY. C.1981; Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolised influenza virus. Infection and Immunology 33:231–238
PrinceG. A.,
Bennett-JensenA.,
HorswoodR. L.,
CamargoE.,
ChanockR. M.1978; The pathogenesis of respiratory syncytial virus infection in cotton rats. American Journal of Pathology 93:771–783
PrinceG. A.,
HemmingV. G.,
HorswoodR. L.,
BaronP. A.,
ChanockR. M.1987; Effectiveness of topically administered neutralising antibody in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. Journal of Virology 61:1851–1854
RoutledgeE. G.,
WillcocksM.M"SAMSON,
MorganL. A.,
ScottR.,
AndersonJ. J.,
TomsG. L.1988; The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice. Journal of General Virology 69:293–303
ScottR.,
DelandazuriM. D.,
GardnerP. S.,
OwenJ.J.T.1976; Detection of antibody to respiratory syncytial virus by membrane fluorescence. Clinical and Experimental Immunology 26:78–85
ScottR.,
KaulA.,
ScottM.CHIBA,
OgraP. L.1978; Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infections in humans. Journal of Infectious Diseases 137:810–817
ScottR.,
ScottM.,
TomsG. L.1981; Cellular and antibody responses to respiratory syncytial (RS) virus in human colostrum, maternal blood and cord blood. Journal of Medical Virology 8:5566
Shapira-NahorO.,
Zakay-RonesZ.1985; Local and peripheral cell mediated immune response to influenza virus in mice. Journal of Medical Virology 15:81–91
SteeleR. W.,
HensenS. A.,
VincentM. M.,
FuccilloD. A.,
BellanttJ.
1973; , A 51Cr microassay technique for cell mediated immunity to viruses. Journal of Immunology 110:1502–1510
SunG. S.,
WydeP. R.,
WilsonS. Z.,
KnightV.1983a; Correlation of cytotoxic activity in the lungs and recovery of normal and gamma-irradiated cotton rats from respiratory syncytial virus infection. American Review of Respiratory Disease 128:668–672
SunG. S.,
WydeP. R.,
KnightV.1983b; Cell mediated cytotoxic responses in lungs of cotton rats infected with respiratory syncytial virus. American Review of Respiratory Disease 127:460–464
TaylorG.,
StottE. J.,
HayleA. J.1985; Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. Journal of General Virology 66:2533–2538
TomsG. L.,
GardnerP. S.,
PullanC. R.,
ScottM.,
TaylorC. E.1980; Secretion of respiratory syncytial virus inhibitors and antibody in human milk throughout lactation. Journal of Medical Virology 5:351–360
WalshE. E.,
SchlesingerJ. J.,
BrandrissM. W.1984; Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infection and Immunity 43:756–758
WelliverR. C.,
KaulA.,
OgraP. L.1979; Cell mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. Journal of Pediatrics 94:370–375
WelliverR. C.,
KaulT. N.,
OgraP. L.1980; The appearance of cell-bound IgE in respiratory tract epithelium after respiratory syncytial virus infection. New England Journal of Medicine 303:1198–1202
WelliverR. C.,
WongT. D.,
SunM.,
MiddletonT.,
VaughanR. S.,
OgraP. L.1981; The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. New England Journal of Medicine 305:841–846
WydeP. R.,
SunC. S.,
KnightV.1983; Replication of respiratory syncytial virus in the lungs of immunodeficient mice. Journal of Reticuloendothelial Society 34:125–129